At HELP Hearing on Prescription Drug Affordability, Senator Collins Questions Expert on Generic Drug Competition
Food and Drug Administration’s (FDA) citizen petition system and FDA’s convoluted process for approving new biosimilars … misuse of the FDA’s citizen petition process, which is sometimes used by drug manufacturers to delay approval